Workshop B: Strategic Decision-Making in Dermatology R&D: Pathway Prioritization, Pipeline Design & Clinical Potential Assessment
Time: 9:00 am
day: PRE-CONFERENCE WORKSHOP DAY Track B P1
Details:
In recent years, the immunodermatology landscape has been expanding with new targets, modalities and evolved pathway understanding. The importance of selecting the “right” targets and constructing a robust future-ready dermatology pipeline for success.
This workshop acts as an opportunity to benchmark approaches with peers, hear case studies on how leading companies have evolved their pipelines, and engage in open discussions unpacking the real-world decision-making
Key Objectives
- Target and Pathway Prioritization: How do R&D leaders determine which interleukins, immune cells, or mechanisms to pursue? What level of translational insight, competitive mapping, and early clinical validation is required to justify target advancement?
- Pipeline Architecture Strategy: How do companies shape their dermatology portfolios – from single-indication blockbusters to modular or multi-asset programs? How do commercial opportunity, patient population needs, and longterm differentiation potential shape early decisions?
- Assessing Clinical and Commercial Innovation Potential: What frameworks do teams use to evaluate whether a candidate brings genuine innovation to the field? What data is needed and when, to gain internal buy-in?
Speakers:
